ProShare Advisors’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

ProShare Advisors’s Portfolio AVNR Stock Details AVNR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-169,549	Closed	-$2.87M	–	2004
2014 Q4	$2.87M	Buy	169,549 +13,052	+8%	+$184K	0.03%	467
2014 Q3	$1.86M	Sell	156,497 -18,425	-11%	-$126K	0.02%	755
2014 Q2	$987K	Sell	174,922 -88,597	-34%	-$408K	0.01%	1170
2014 Q1	$967K	Buy	263,519 +188,864	+253%	+$720K	0.01%	1334
2013 Q4	$251K	Sell	74,655 -68,101	-48%	-$281K	﹤0.01%	1213
2013 Q3	$605K	Buy	142,756 +20,703	+17%	+$98.1K	0.01%	1300
2013 Q2	$561K	Buy	+122,053	New	+$420K	0.01%	1242

ProShare Advisors's AVNR Position: Q1 2015 in Review

ProShare Advisors sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q1 2015, closing a stake of 169,549 shares — an estimated $2.87M sold.

ProShare Advisors first reported a position in AVNR in Q2 2013 and held it in 7 quarters. The position peaked at $2.87M in Q4 2014. 0 funds tracked by Wall St. Rank hold AVNR as of Q1 2015.

ProShare Advisors reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q1 2015 after selling out during the quarter.
ProShare Advisors sold 169,549 AVANIR PHARMACEUTICALS, INC CL A shares in Q1 2015, an estimated $2.87M.
ProShare Advisors first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q2 2013 and held it in 7 quarters.
ProShare Advisors's AVANIR PHARMACEUTICALS, INC CL A position peaked at $2.87M in Q4 2014.
0 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q1 2015.

Based on ProShare Advisors's 13F filing for Q1 2015, filed 8 May 2015.